ArticleContact in context2026
Spectrometric Assessment of Intralot and Interlot Variability in Mycophenolate Mofetil for Injection Using Near-Infrared Spectrometry and Nonparametric Subcluster Detection.
Article in Contact in context, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Mycophenolate Mofetil for Injection is an antimetabolite immunosuppressant supplied as a sterile, lyophilized powder containing 500 mg of active drug per single-dose vial for intravenous administration. As a prodrug of mycophenolic acid, it selectively and reversibly inhibits inosine monophosphate dehydrogenase to block de novo guanosine nucleotide synthesis and suppress lymphocyte proliferation, carrying boxed warnings for embryofetal toxicity, serious opportunistic infections, and malignancies. Nondestructive Fourier transform near-infrared spectrometry coupled with principal component analysis and the Bootstrap Error-Adjusted Single-sample Technique was utilized to evaluate intralot and interlot spectral consistency across drug vials. Intra-lot analysis of a single 15-vial batch (Lot 2515203) revealed heterogeneity and outliers, with individual vials deviating up to 11.6 multidimensional standard deviations from the main cluster center. Interlot evaluation of a 464-vial spectral library spanning 18 distinct manufacturing lots demonstrated persistent two-group subclustering, with Principal Component 1 accounting for only 87.82% of total spectral variance. Nonparametric FSOB density estimation confirmed statistically significant subclustering across the multi-lot library (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.